本文選題：藥師 + 居家用藥評(píng)估　； 參考：《中國(guó)現(xiàn)代應(yīng)用藥學(xué)》2016年01期

【摘要】：目的系統(tǒng)評(píng)價(jià)國(guó)內(nèi)外居家用藥評(píng)估(Home medicines review,HMR)服務(wù)的實(shí)施現(xiàn)狀。方法計(jì)算機(jī)檢索以下數(shù)據(jù)庫(kù):Cochrane Library、Pub Med、Embase、CNKI、CBM、VIP和萬(wàn)方數(shù)據(jù)庫(kù),檢索時(shí)間截止2014年9月。納入HMR相關(guān)的中英文研究,對(duì)所納入的RCT文獻(xiàn),采用Rev Man 5.1軟件進(jìn)行Meta分析,其余文獻(xiàn)采用描述性分析。結(jié)果共納入27項(xiàng)研究,其中包括10項(xiàng)RCTs,17項(xiàng)其他研究。Meta分析顯示,HMR組較對(duì)照組的藥物相關(guān)問(wèn)題減少20.8%~70.4%;HMR組的再入院率高于對(duì)照組(38.34%vs 33.63%),但差異無(wú)統(tǒng)計(jì)學(xué)意義(P=0.64);死亡率未明顯降低,差異無(wú)統(tǒng)計(jì)學(xué)意義。HMR組較對(duì)照組的滿意度高,2組HMR接受度及生活質(zhì)量評(píng)分差異均無(wú)統(tǒng)計(jì)學(xué)意義。HMR的實(shí)施困難包括醫(yī)師、藥師、患者及模式自身問(wèn)題。結(jié)論實(shí)施HMR面臨多方面困難,HMR是否能顯著改善患者各項(xiàng)結(jié)局指標(biāo)還有待更多大樣本、高質(zhì)量研究來(lái)證實(shí)。
[Abstract]:Objective to evaluate the status of Home medicines Review (HMRs) service at home and abroad. Methods the following databases were searched by computer: Cochrane Library Pub Medbase (CNKI) CBMU VIP and Wanfang database. The retrieval time was up to September 2014. The Chinese and English studies related to HMR were included. The RCT literature was analyzed by Rev Man 5.1 software and the rest by descriptive analysis. Results A total of 27 studies were included, including 10 RCTsN 17 other studies. Meta-analysis showed that the readmission rate in HMR group was higher than that in control group (38.34 vs 33.63), but there was no significant difference between HMR group and control group. The difference of HMR acceptance and quality of life score between the two groups was not statistically significant. The difficulty of implementing HMR included doctors, pharmacists, patients and the model itself. Conclusion there are many difficulties in the implementation of HMR.
【作者單位】： 重慶醫(yī)科大學(xué)附屬第一醫(yī)院藥學(xué)部;
【分類號(hào)】：R95
，

本文編號(hào)：1946671